Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence.
Semergen
; 50(4): 102132, 2024.
Article
in En
| MEDLINE
| ID: mdl-38295632
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunogenicity, Vaccine
/
COVID-19 Vaccines
/
COVID-19
/
BNT162 Vaccine
Limits:
Humans
Language:
En
Journal:
Semergen
Year:
2024
Document type:
Article
Country of publication: